Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RION CoRIOXF 91 3-Year EPS without NRI Growth Rate is 9.80% as of Jun. 2026, which is 62% above its 10-year median of 6.05. GuruFocus rates RIOXF with a GF Score™ of 91/100 and a GF Value™ of $12.36. The stock has 1 warning sign investors should review. Among 662 Medical Devices & Instruments companies, RION Co ranks better than 52.42% on this metric.
During the past 12 months, RION Co's average EPS without NRI Growth Rate was -16.40% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 9.80% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 14.10% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 3.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of RION Co was 19.60% per year. The lowest was -25.10% per year. And the median was 6.05% per year.
RION Co (OTCPK:RIOXF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
RION Co 3-Year EPS without NRI Growth Rate Related Terms
RIOXF vs ABT, SYK, MDT: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, RION Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RION Co 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, RION Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where RION Co's 3-Year EPS without NRI Growth Rate falls into.
RION Co 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 9.80% mean?
RION Co (RIOXF) has a 3-Year EPS without NRI Growth Rate of 9.80% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for RION Co and its competitors. This is 62% above median its historical median of 6.05. According to the industry distribution chart, RION Co ranks #315 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 47.6%.
Is RION Co's 3-Year EPS without NRI Growth Rate too high?
RION Co's current 3-Year EPS without NRI Growth Rate of 9.80% is 62% above median its 10-year median of 6.05. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 8.05. RION Co's value of 9.80% is 21.7% above this industry median. Based on the distribution chart, RION Co ranks #315 out of 662 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, RION Co has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does RION Co's 3-Year EPS without NRI Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, RION Co ranks #315 out of 662 companies for 3-Year EPS without NRI Growth Rate. This puts RION Co in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 8.05. RION Co's value of 9.80% is 21.7% above this benchmark. While the company's 10-year median is 6.05 vs. the industry median of 8.05, RION Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 8.05, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RION Co's current 3-Year EPS without NRI Growth Rate of 9.80% is 21.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for RION Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RION Co's current 3-Year EPS without NRI Growth Rate is 9.80%, which is 62% above median its own 10-year median of 6.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RION Co stock overvalued right now?
RION Co (RIOXF) has a current 3-Year EPS without NRI Growth Rate of 9.80%. The stock's GF Value™ is $12.36, compared to a current price of $14.63 — trading 18.4% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 9.80%, which is 62% above median its 10-year median of 6.05 and 21.7% above the Medical Devices & Instruments industry median of 8.05. RION Co's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For RION Co (RIOXF), the current 3-Year EPS without NRI Growth Rate is 9.80% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RION Co (RIOXF) Overvalued in 2026?
Based on GuruFocus' analysis, RION Co stock appears to be overvalued.
The current stock price of $14.63 is trading 18.4% above its estimated GF Value™ of $12.36.
Key valuation signals for RIOXF:
3-Year EPS without NRI Growth Rate: 9.80% (62% above median its 10-year median of 6.05)
GF Value™: $12.36 vs. price of $14.63 (18.4% above fair value)
Industry Position: 21.7% above the Medical Devices & Instruments median (#315 of 662)
No single metric tells the full story. See the RIOXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RION Co Ltd is engaged in manufacturing and selling of maintenance services of a medical device. The company offers hearing instruments and medical equipment, an environmental device including sound and vibration measuring instruments and particle counters and parts and equipment.
91GF Score
Get the complete analysis for RIOXF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RIOXF has been successfully added to your 
